PSUNRISE - Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept

NCT00527072 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

217

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

BIOLOGICAL: infliximab

Sponsor

Centocor Ortho Biotech Services, L.L.C.